Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies
- PMID: 9041182
Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies
Abstract
Inactivation of the cyclin-dependent kinase inhibitors p16INK4A and p15INK4B are frequent alterations in neoplasia, often resulting from homozygous deletion or promoter region hypermethylation. We have analyzed both modes of inactivation of p15INK4B and p16INK4A in the major types of adult and pediatric hematological malignancies. Hypermethylation of p15INK4B, without alteration of p16INK4A, was an almost universal finding in adult acute myelogenous leukemia, and occurred very frequently in adult acute lymphocytic leukemia and pediatric acute myelogenous leukemia and acute lymphocytic leukemia. In contrast, neither p15INK4B nor p16INK4A were inactivated in any stage of chronic myelogenous leukemia. Hypermethylation of p16INK4A, often without alterations of p15INK4B, was found in non-Hodgkin's lymphoma and was much more frequent in cases with high-grade than low-grade histology. Enriched normal bone marrow stem cells had no detectable promoter region methylation of these genes, as analyzed by a newly developed PCR method. Remarkably distinct patterns of inactivation of p15INK4B and p16INK4A characterize different types of hematological malignancy, and alterations in these tumor suppressor genes are one of the most common alterations in hematological malignancies.
Similar articles
-
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.Cancer Res. 1996 Feb 15;56(4):722-7. Cancer Res. 1996. PMID: 8631003
-
Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.Oncogene. 1997 Mar 20;14(11):1361-70. doi: 10.1038/sj.onc.1200969. Oncogene. 1997. PMID: 9178896
-
Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.Oncogene. 1999 Jan 14;18(2):385-96. doi: 10.1038/sj.onc.1202299. Oncogene. 1999. PMID: 9927195
-
[Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].Bull Cancer. 1998 Sep;85(9):747-54. Bull Cancer. 1998. PMID: 9817058 Review. French.
-
p16ink4a gene and hematological malignancies.Leuk Lymphoma. 1996 Jun;22(1-2):11-24. doi: 10.3109/10428199609051724. Leuk Lymphoma. 1996. PMID: 8724524 Review.
Cited by
-
Methylation status of DDIT3 gene in chronic myeloid leukemia.J Exp Clin Cancer Res. 2010 May 23;29(1):54. doi: 10.1186/1756-9966-29-54. J Exp Clin Cancer Res. 2010. PMID: 20492726 Free PMC article.
-
Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.J Cancer Res Clin Oncol. 2011 Dec;137(12):1831-40. doi: 10.1007/s00432-011-1065-2. Epub 2011 Sep 16. J Cancer Res Clin Oncol. 2011. PMID: 21922325
-
Novel agents for the treatment of childhood acute leukemia.Ther Adv Hematol. 2015 Apr;6(2):61-79. doi: 10.1177/2040620714565963. Ther Adv Hematol. 2015. PMID: 25830014 Free PMC article. Review.
-
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.Leukemia. 2012 May;26(5):1106-7. doi: 10.1038/leu.2011.342. Epub 2011 Nov 29. Leukemia. 2012. PMID: 22124213 Free PMC article. No abstract available.
-
Urinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression models.PLoS One. 2012;7(12):e50471. doi: 10.1371/journal.pone.0050471. Epub 2012 Dec 5. PLoS One. 2012. PMID: 23227177 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical